| AGO | Argonaute |
| AGO2 | Argonaute RISC Catalytic Component 2 |
| ALS | Amyotrophic lateral sclerosis |
| ASO | Antisense oligonucleotides |
| CLL | Chronic lymphocytic leukemia |
| CTCL | Cutaneous T-cell lymphoma |
| ATLL | Adult T-cell leukemia/lymphoma |
| COVID-19 | Coronavirus disease 2019 |
| DICER1 | Dicer 1, Ribonuclease III |
| DLBCL | Diffuse large B-cell lymphoma |
| EGFR | Epidermal growth factor receptor |
| DGCR8 | DiGeorge syndrome critical region 8 |
| DROSHA | Drosha Ribonuclease III |
| EVs | Extracellular vesicles |
| GalNAc | N-acetylgalactosamine |
| HCV | Hepatitis C virus |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| LNA | Locked nucleic acid |
| MF | Mycosis fungoides |
| mRNA | messenger RNA |
| miRNA | microRNA |
| ncRNAs | non-coding RNAs |
| P-bodies | Processing bodies |
| PNA | Peptide nucleic acid |
| pre-miRNA | precursor microRNA |
| pri-miRNA | primary microRNA |
| RNA Pol II | RNA polymerase II |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| sgRNA | Single guide RNA |
| siRNA | Small interfering RNA |
| TDMD | Target-directed miRNA degradation mechanism |
| TME | Tumor microenvironment |
| TRBP | The TAR RNA-binding protein |
| TTR | Transthyretin |
| UTR | Untranslated region |
| XenomiRs | Exogenous miRNAs |
| XPO5 | Exportin 5 |